Delivery Order SPE2DB20D7059-SPE2DB24FQLA9

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,131.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. The contract is for the delivery of 4,562,879,147 units of acetazolamide 250 mg tablets, a generic pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,953.54 Firm Fixed Price Delivery Order contract is for the supply of 4,564,743,033 units of Acetazolamide 250 mg tablets, a medication used to treat various medical conditions. The contract has an ultimate completion date of May 30, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Acetazolamide ER 500 mg capsules. The contract has a firm-fixed price with a not-to-exceed value of $3,702.84 and an ultimate completion date of August 13, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical worth up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,433.18 firm fixed-price delivery order is for the supply of Acetazolamide ER 500 mg capsules, with a performance period ending on May 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,752.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACETAZOLAMIDE ER 500 MG CAP 60S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4564001882 - ACETAZOLAMIDE ER 500 MG CAP 60S. The contract has a total ceiling value of $1,748.40 and a performance period through March 19, 2024. This award is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the provision of ACETAZOLAMIDE ER 500 MG CAP 60S, a pharmaceutical product, with a potential value of $3,645.05 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designation. The...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ACETAMINOPHEN 1000MG/100ML BAG 100ML. The contract has a ceiling value of $1,008.75 and a period of performance through June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,231.25 firm fixed-price delivery order is for the supply of 4,568,235,107 units of the medication Methazolamide 50 mg tablets. The award is not set-aside and has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of medical products including acetaminophen. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,290.40. The contract has a period of performance through May 15, 2025. This contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQLA9
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Acetazolamide 250 mg tablets. The contract has a firm fixed-price with a ceiling value of $1,115.01 and is set to expire on August 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/12/24, 9:13 AM